AngelMed Guardian System
FDA premarket approval P150009/S007 · decided 2022-05-19
Approval details
- PMA number
- P150009
- Supplement
- S007
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol
- Trade name
- AngelMed Guardian System
- Generic name
- Acute coronary syndrome event detector
- Applicant
- Avertix Medical, Inc.
- Date received
- 2022-04-27
- Decision date
- 2022-05-19
- Days to decision
- 22 days
- Decision code
- APPR
- Product code
- QBI
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Eatontown, NJ
- Statement
- Approval of the revised protocol for the AngelMed Guardian post-approval study.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.